Ch. Kao et al., A COMPARATIVE-STUDY OF 99TCM-HMPAO AND 99TCM-ECD AS A LEUKOCYTE LABELING AGENT, Nuclear medicine communications, 15(4), 1994, pp. 294-297
An attempt was made to use Tc-99m-ethyl cysteinate dimer (Tc-99m-ECD)
(Neurolite, Du Pont Merck, N. Billerica, MA) to label leukocytes. The
radiochemical purity of Tc-99m-ECD, labelling efficiency of leukocytes
, cell viability of labelled leukocytes and stability of Tc-99m-ECD-la
belled leukocytes were calculated. Compared with the commercial cell-l
abelling agent, Tc-99m-hexamethylpropyleneamine oxime (Tc-99m-HMPAO):
(1) the radiochemical purity of Tc-99m-ECD was higher than that of Tc-
99m-HMPAO and at immediately, 1, 2, 4, 6, 8 and 24 h after Tc-99m labe
lling; (2) the labelling efficiency of Tc-99m-ECD-labelled leukocytes
was lower than that of Tc-99m-HMPAO; (3) the viability of the labelled
white blood cells (WBC) was high for both agents; and (4) the stabili
ty of Tc-99m-ECD-labelled leukocytes was worse than that of Tc-99m-HMP
AO at 1, 2, 4, 6, 8 and 24 h. It is concluded that although Tc-99m-ECD
is more stable than Tc-99m-HMPAO, because of the lower labelling effi
ciency and poorer stability of Tc-99m-ECD-labelled leukocytes, Tc-99m-
ECD is not a good choice as a leukocyte-labelling agent to replace com
mercial Tc-99m-HMPAO.